East Hanover, NJNCT07408219Now EnrollingIRB Ready

Chronic Spontaneous Urticaria Clinical Trial in East Hanover, NJ

Access cutting-edge chronic spontaneous urticaria treatment through this clinical trial at a research site in East Hanover. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this East Hanover location

Preparing your pre-screening questions…

Expert Care in East Hanover

Access chronic spontaneous urticaria specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic spontaneous urticaria treatment provided free

Apply for This East Hanover Location

Check if you qualify for this chronic spontaneous urticaria clinical trial in East Hanover, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Hanover

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Hanover site if eligible
  4. 4Begin participation

About This Chronic Spontaneous Urticaria Study in East Hanover

This is a United States (US) based, prospective, non-interventional, provider-referral study to evaluate the real-world effectiveness and patient-centered outcomes of remibrutinib in chronic spontaneous urticaria (CSU) patients using validated patient reported outcome (PRO) tools.

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Healthcare provider (HCP) participants eligible to refer patients for inclusion in this study must meet all the following criteria:
Have an active medical license and be board certified/board eligible allergist or dermatologist in the US. Nurse practitioners and physician assistant practicing in allergy and dermatology are eligible.
Manage CSU patients within their practice.
Enrolled in the research network or are referred HCPs who agree to participate.
Have the requisite patient population based on study inclusion/

Exclusion Criteria

. Patients eligible for inclusion in this study must meet all of the following criteria:
≥ 18 years of age.
Diagnosed with CSU by an HCP.
Have received a prescription for remibrutinib or dupilumab and are expected to initiate treatment.
Have access to an electronic device with internet capabilities.
Able to read and understand English.
Willing and able to provide consent for study participation. Exclusion criteria: Patients will be excluded if they meet any of the following criteria:
Unable to procure remibrutinib or dupilumab (through samples, commercially or patient assistance program).
Exposure to oral corticosteroid treatment in 14 days prior to consent.
Exposure to oral corticosteroid treatment in 14 days prior to initiating treatment with remibrutinib or dupilumab.
Prior participation in a remibrutinib or dupilumab clinical trial.
Cognitive impairment that impacts the patient's ability to participate.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Hanover?

Yes, this clinical trial (NCT07408219) has an active research site in East Hanover, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Spontaneous Urticaria Treatment Options in East Hanover, NJ

If you're searching for chronic spontaneous urticaria treatment options in East Hanover, NJ, this clinical trial (NCT07408219) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Hanover research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic spontaneous urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic spontaneous urticaria clinical trials near you to find additional studies recruiting in your area.

More Chronic Urticaria Trials in East Hanover, NJ

See all chronic urticaria clinical trials recruiting in East Hanover — not just this study.

Browse Chronic Urticaria Trials in East Hanover →

Browse More Trials by Condition

Chronic Urticaria TrialsInterstitial Cystitis TrialsChronic Spontaneous Urticaria TrialsUrticaria TrialsAll Conditions →

Ready to Join in East Hanover?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Hanover, NJ